DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
53 hedge funds and large institutions have $47.5M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.92M | |
| 2 | +$449K | |
| 3 | +$183K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$170K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$163K |
Top Sellers
| 1 | -$4.19M | |
| 2 | -$1.12M | |
| 3 | -$1M | |
| 4 |
OPPM
Opus Point Partners Management
New York
|
-$579K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$419K |